Fig. 5
From: Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis
Ceramides were significantly elevated in NASH subjects. a Serum sphingolipids in normal subjects and patients with NAFL, NASH, CHB with or without NASH. b Analysis of specific ceramide species in five subgroups. c analysis of serum sphingolipids in control, non-NASH subjects (NAFL and CHB without NASH) and NASH subjects (NASH and CHB with NASH). d-h Comparison of specific ceramide species between the non-NASH subjects (NAFL and CHB without NASH) and the NASH subjects (NASH and CHB with NASH)